ESR2 and laryngeal carcinoma: The integrative, synergistic, or alternatively antagonistic effects of ERs cause variable response and reaction to E2. This is emphasized by the actions of the three central receptors, ERα66, ERα36 and ERβ, identified in laryngeal cancer cells.